| Mutational dynamics between primary and relapse neuroblastomas A Schramm, J Köster, Y Assenov, K Althoff, M Peifer, E Mahlow, ... Nature genetics 47 (8), 872-877, 2015 | 375 | 2015 |
| EDGAR 2.0: an enhanced software platform for comparative gene content analyses J Blom, J Kreis, S Spänig, T Juhre, C Bertelli, C Ernst, A Goesmann Nucleic acids research 44 (W1), W22-W28, 2016 | 369 | 2016 |
| Computational pan-genomics: status, promises and challenges Briefings in bioinformatics 19 (1), 118-135, 2018 | 338 | 2018 |
| Gene panel testing of 5589 BRCA1/2‐negative index patients with breast cancer in a routine diagnostic setting: results of the German Consortium for Hereditary … J Hauke, J Horvath, E Groß, A Gehrig, E Honisch, K Hackmann, ... Cancer medicine 7 (4), 1349-1358, 2018 | 171 | 2018 |
| BRIP1 loss-of-function mutations confer high risk for familial ovarian cancer, but not familial breast cancer N Weber-Lassalle, J Hauke, J Ramser, L Richters, E Groß, B Blümcke, ... Breast Cancer Research 20, 1-6, 2018 | 129 | 2018 |
| Performance of in silico prediction tools for the classification of rare BRCA1/2 missense variants in clinical diagnostics C Ernst, E Hahnen, C Engel, M Nothnagel, J Weber, RK Schmutzler, ... BMC medical genomics 11, 1-10, 2018 | 110 | 2018 |
| Association Between Loss-of-Function Mutations Within the FANCM Gene and Early-Onset Familial Breast Cancer G Neidhardt, J Hauke, J Juliane Ramser, E Groß, A Gehrig, CR Müller, ... JAMA Oncology, 2016 | 99 | 2016 |
| How to make a tumour: cell type specific dissection of Ustilago maydis‐induced tumour development in maize leaves A Matei, C Ernst, M Günl, B Thiele, J Altmüller, V Walbot, B Usadel, ... New Phytologist 217 (4), 1681-1695, 2018 | 68 | 2018 |
| Germline loss-of-function variants in the BARD1 gene are associated with early-onset familial breast cancer but not ovarian cancer N Weber-Lassalle, J Borde, K Weber-Lassalle, J Horváth, D Niederacher, ... Breast Cancer Research 21, 1-6, 2019 | 64 | 2019 |
| Association of germline variant status with therapy response in high-risk early-stage breast cancer: a secondary analysis of the GeparOcto randomized clinical trial E Pohl-Rescigno, J Hauke, S Loibl, V Moebus, C Denkert, PA Fasching, ... JAMA oncology 6 (5), 744-748, 2020 | 49 | 2020 |
| Deleterious somatic variants in 473 consecutive individuals with ovarian cancer: results of the observational AGO-TR1 study (NCT02222883) J Hauke, E Hahnen, S Schneider, A Reuss, L Richters, S Kommoss, ... Journal of medical genetics 56 (9), 574-580, 2019 | 44 | 2019 |
| Performance of Breast Cancer Polygenic Risk Scores in 760 Female CHEK2 Germline Mutation Carriers J Borde, C Ernst, B Wappenschmidt, D Niederacher, K Weber-Lassalle, ... JNCI: Journal of the National Cancer Institute 113 (7), 893-899, 2021 | 33 | 2021 |
| PanCake: a data structure for pangenomes C Ernst, S Rahmann German conference on bioinformatics 2013, 2013 | 29 | 2013 |
| Diagnosis of Li‐Fraumeni Syndrome: Differentiating TP53 germline mutations from clonal hematopoiesis: Results of the observational AGO‐TR1 trial K Weber‐Lassalle, P Harter, J Hauke, C Ernst, S Kommoss, F Marmé, ... Human mutation 39 (12), 2040-2046, 2018 | 26 | 2018 |
| Cell type specific transcriptional reprogramming of maize leaves during Ustilago maydis induced tumor formation M Villajuana-Bonequi, A Matei, C Ernst, A Hallab, B Usadel, ... Scientific Reports 9 (1), 10227, 2019 | 25 | 2019 |
| Clonal hematopoiesis–associated gene mutations in a clinical cohort of 448 patients with ovarian cancer K Weber-Lassalle, C Ernst, A Reuss, K Möllenhoff, K Baumann, ... JNCI: Journal of the National Cancer Institute 114 (4), 565-570, 2022 | 22 | 2022 |
| Prevalence of cancer predisposition germline variants in male breast cancer patients: results of the German consortium for hereditary breast and ovarian cancer M Rolfes, J Borde, K Möllenhoff, M Kayali, C Ernst, A Gehrig, C Sutter, ... Cancers 14 (13), 3292, 2022 | 14 | 2022 |
| Ovarian Cancer–Specific BRCA-like Copy-Number Aberration Classifiers Detect Mutations Associated with Homologous Recombination Deficiency in the AGO … PC Schouten, L Richters, DJ Vis, S Kommoss, E van Dijk, C Ernst, ... Clinical Cancer Research 27 (23), 6559-6569, 2021 | 11 | 2021 |
| Performance of in silico prediction tools for the detection of germline copy number variations in cancer predisposition genes in 4208 female index patients with familial breast … L Lepkes, M Kayali, B Blümcke, J Weber, M Suszynska, S Schmidt, ... Cancers 13 (1), 118, 2021 | 11 | 2021 |
| Polygenic risk scores indicate extreme ages at onset of breast cancer in female BRCA1/2 pathogenic variant carriers J Borde, Y Laitman, B Blümcke, D Niederacher, K Weber-Lassalle, ... BMC cancer 22 (1), 706, 2022 | 9 | 2022 |
